World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
119
Citations
43140
World Ranking
348
National Ranking
221

Medicine

D-Index
119
Citations
43225
World Ranking
3940
National Ranking
2157

Peter L. Collins publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter L. Collins sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 422 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Peter L. Collins D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter L. Collins sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 119 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Peter L. Collins is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on Medicine, with a significant number of publications in Epidemiology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Infectious Diseases, and Physiology.

Their work frequently addresses topics related to respiratory viral infections research, virology and viral diseases, pneumonia and respiratory infections, tracheal and airway disorders, sarcoidosis and beryllium toxicity research, influenza virus research studies, and neonatal respiratory health research.

Recent papers authored or co-authored by Peter L. Collins include:

  • Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children, 2020, American Journal of Respiratory and Critical Care Medicine
  • Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children, 2020, The Journal of Infectious Diseases
  • A systematic scoping review on the evidence behind debriefing practices for the wellbeing/emotional outcomes of healthcare workers, 2023, Frontiers in Psychiatry
  • Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children, 2022, The Journal of Infectious Diseases
  • Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects, 2021, Science Translational Medicine

Peter L. Collins has collaborated frequently with several co-authors, including:

  • Raheel Ahmed
  • Ursula J. Buchholz
  • Raymond J. Pickles
  • Ruth A. Karron
  • Cindy Luongo

Publications by Peter L. Collins appear often in the following venues:

  • UNC Libraries
  • Journal of Virology
  • The Journal of Infectious Diseases
  • Proceedings of the National Academy of Sciences
  • PLoS ONE

Best Publications

  • The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins

    Philip R. Johnson;Melanie K. Spriggs;Robert A. Olmsted;Peter L. Collins

  • Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development

    Peter L. Collins;Myron G. Hill;Ena Camargo;Haim Grosfeld

  • Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology

    Liqun Zhang;Mark E. Peeples;Richard C. Boucher;Peter L. Collins

  • Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis

    Peter L. Collins;Barney S. Graham

  • Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

    Peter L. Collins;José A. Melero

  • Taxonomy of the order Mononegavirales: update 2016

    Claudio L. Afonso;Gaya K. Amarasinghe;Krisztián Bányai;Yīmíng Bào

  • Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

    Himani Bisht;Anjeanette Roberts;Leatrice Vogel;Alexander Bukreyev

  • A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease

    Fernando P. Polack;Michael N. Teng;Peter L. Collins;Gregory A. Prince

  • Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity

    Robert A. Olmsted;Narayanasamy Elango;Gregory A. Prince;Brian R. Murphy

  • Severe Acute Respiratory Syndrome Coronavirus Infection of Human Ciliated Airway Epithelia: Role of Ciliated Cells in Viral Spread in the Conducting Airways of the Lungs

    Amy C. Sims;Ralph S. Baric;Boyd Yount;Susan E. Burkett

  • Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.

    Louay K. Hallak;Dorothe Spillmann;Peter L. Collins;Mark E. Peeples

  • Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein

    G W Wertz;P L Collins;Y Huang;C Gruber

  • Cardiovascular protection by oestrogen—a calcium antagonist effect?

    P. Collins;G.M.C. Rosano;C. Jiang;D. Lindsay

  • Suppression of the Induction of Alpha, Beta, and Gamma Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages

    Unknown

  • Normal and Cystic Fibrosis Airway Surface Liquid Homeostasis THE EFFECTS OF PHASIC SHEAR STRESS AND VIRAL INFECTIONS

    Robert Tarran;Brian Button;Maryse Picher;Anthony M. Paradiso

  • Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

    Ursula J. Buchholz;Alexander Bukreyev;Lijuan Yang;Elaine W. Lamirande

  • Taxonomy of the order Mononegavirales: update 2018

    Gaya K. Amarasinghe;Nidia G. Aréchiga Ceballos;Ashley C. Banyard;Christopher F. Basler

  • Effects of Nonstructural Proteins NS1 and NS2 of Human Respiratory Syncytial Virus on Interferon Regulatory Factor 3, NF-κB, and Proinflammatory Cytokines

    Kirsten M. Spann;Kim C. Tran;Peter L. Collins

  • Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus

    Peter L. Collins;Yung T. Huang;Gail W. Wertz

  • Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.

    P R Johnson;R A Olmsted;G A Prince;B R Murphy

  • Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse.

    Alexander Bukreyev;Stephen S. Whitehead;Brian R. Murphy;Peter L. Collins

  • Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

    Alexander Bukreyev;Elaine W Lamirande;Ursula J Buchholz;Leatrice N Vogel

  • Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway Epithelium

    Liqun Zhang;Alexander Bukreyev;Catherine I. Thompson;Brandy Watson

  • Iduronic Acid-Containing Glycosaminoglycans on Target Cells Are Required for Efficient Respiratory Syncytial Virus Infection

    Louay K. Hallak;Peter L. Collins;Warren Knudson;Mark E. Peeples;Mark E. Peeples

  • RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA.

    H Grosfeld;M G Hill;P L Collins

  • Respiratory Syncytial Virus: Virology, Reverse Genetics, and Pathogenesis of Disease

    Peter L. Collins;Rachel Fearns;Barney S. Graham

  • Taxonomy of the order Mononegavirales: update 2017

    Gaya K. Amarasinghe;Yīmíng Bào;Christopher F. Basler;Sina Bavari

Frequent Co-Authors

Brian R. Murphy
Brian R. Murphy National Institute of Allergy and Infectious Diseases
Ursula J. Buchholz
Ursula J. Buchholz National Institutes of Health
Siba K. Samal
Siba K. Samal University of Maryland, College Park
Alexander Bukreyev
Alexander Bukreyev The University of Texas Medical Branch at Galveston
Mark E. Peeples
Mark E. Peeples The Ohio State University
Ruth A. Karron
Ruth A. Karron Johns Hopkins University
Raymond J. Pickles
Raymond J. Pickles University of North Carolina at Chapel Hill
Robert M. Chanock
Robert M. Chanock National Institutes of Health
Stephen S. Whitehead
Stephen S. Whitehead National Institute of Allergy and Infectious Diseases
Philip R. Johnson
Philip R. Johnson Children's Hospital of Philadelphia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA often opens doors to diverse healthcare careers, many of which benefit from advanced nursing qualifications. For those interested in clinical roles, exploring an accelerated NP program can fast-track your journey from a registered nurse to a Nurse Practitioner (NP), equipping you with specialized skills for complex patient care scenarios.

If you're already a Family Nurse Practitioner, transitioning to more specialized roles like an fnp to acute care np path can broaden your expertise and enhance your career prospects in acute and critical care settings. This transition addresses the growing demand for highly skilled practitioners in hospital environments.

For those without a nursing background, enrolling in online RN programs for non nurses offers a flexible pathway to enter the nursing profession and eventually integrate with immunology-related healthcare fields. These programs make nursing education accessible without the need for previous clinical experience.

Understanding potential earnings is also important when choosing a career path. Resources on dnp salary transparency provide valuable insights into salary variations across states, helping you make informed decisions about both education and employment locations.

Best Scientists Citing Peter L. Collins

Trending Scientists

Recently Published Articles